Advanced search

Combine gene, variant, phenotype, region and year filters

Every result shows the extracted entities next to the sentences that support them; rows for the searched entities come first.

Transparent by designEvery result links extracted entities to its source sentence and publication identifier.
About your search

CD38 and lymphoma are reported together in 1 article.

Gene

CD38

HGNC
HGNC:1667
22articles
22mentions
0variants with confirmed gene link
Most co-reported phenotypes (articles)
Phenotype

Lymphoma

428articles
428mentions
12co-reported genes shown
Most co-reported genes (articles)

Counts are literature co-mentions in SaudiVarKB, not clinical or causal assertions. Gene details: HGNC; variant status: ClinVar via dbSNP.

Publications

1 records shown · first 60

Clinicopathologic features of plasmablastic lymphoma: Single-center series of 8 cases from Saudi Arabia.

PMID 26108914 | PMCID PMC4479229 | DOI 10.1186/s13000-015-0315-z · Diagnostic pathology · 2015 · 3 validated mentions
TypeEntitySource evidenceConfidenceExtractor
geneCD38“A broad immunohistochemical panel consisting of CD45, CD3, CD20, CD79a, Pax5, CD38, CD138, MUM1, EMA, Kappa, Lambda, CD 56, CD30, Bcl-2, Bcl-6, Alk-1, Ki-67, EBV-LMP-1, and HHV8 was performed.”0.98hgnc_dict_v1
phenotypelymphoma“Clinicopathologic features of plasmablastic lymphoma: Single-center series of 8 cases from Saudi Arabia.”0.98phenotype_alias_lexicon_v2
populationSaudi Arabia“Clinicopathologic features of plasmablastic lymphoma: Single-center series of 8 cases from Saudi Arabia. PBL has been reported in several other countries; however, there have been no reported cases from Saudi Arabia. Similar to previously published studies, PBL in Saudi Arabia is characterized by male predominance (6/8), median age 51.5 years (mean age 46 years), associated with early dissemination, poor response to therapy, and limited survival (average survival time, 6.4 months, median overall survival 5.5 months).”0.95saudi_context_rules_v1